[HTML][HTML] Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice
CL Parish, G Castelo-Branco, N Rawal… - The Journal of …, 2008 - Am Soc Clin Investig
Dopamine (DA) cell replacement therapy in Parkinson disease (PD) can be achieved using
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
[HTML][HTML] Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice
CL Parish, G Castelo-Branco, N Rawal… - The Journal of …, 2008 - ncbi.nlm.nih.gov
Dopamine (DA) cell replacement therapy in Parkinson disease (PD) can be achieved using
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice.
CL Parish, G Castelo-Branco, N Rawal… - The Journal of …, 2008 - europepmc.org
Dopamine (DA) cell replacement therapy in Parkinson disease (PD) can be achieved using
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice
CL Parish, G Castelo-Branco, N Rawal… - Journal of Clinical …, 2008 - lup.lub.lu.se
Dopamine (DA) cell replacement therapy in Parkinson disease (PD) can be achieved using
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice
CL Parish, G Castelo-Branco, N Rawal, J Tonnesen… - 2008 - Am Soc Clin Investig
Dopamine (DA) cell replacement therapy in Parkinson disease (PD) can be achieved using
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
[PDF][PDF] Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice
CL Parish, G Castelo-Branco, N Rawal, J Tonnesen… - Am Soc Clin Investig
Dopamine (DA) cell replacement therapy in Parkinson disease (PD) can be achieved using
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice
CL Parish, G Castelo-Branco, N Rawal… - Journal of Clinical …, 2008 - portal.research.lu.se
Dopamine (DA) cell replacement therapy in Parkinson disease (PD) can be achieved using
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice
CL Parish, G Castelo-Branco, N Rawal… - Journal of Clinical …, 2008 - search.proquest.com
Dopamine (DA) cell replacement therapy in Parkinson disease (PD) can be achieved using
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
[PDF][PDF] Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice
CL Parish, G Castelo-Branco, N Rawal, J Tonnesen… - academia.edu
Dopamine (DA) cell replacement therapy in Parkinson disease (PD) can be achieved using
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
human fetal mesencephalic tissue; however, limited tissue availability has hindered further …
[引用][C] Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice
CL Parish, G Castelo-Branco, N Rawal… - Journal of Clinical …, 2008 - cir.nii.ac.jp
Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in
parkinsonian mice | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
parkinsonian mice | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …